Accelerate Diagnostics Inc. – NasdaqCM: AXDX
The insiders have suddenly started huge buys and other acquisitions of shares of AXDX. Directors and board members have acquired 2, 153,650 shares valued at $17,528,114 during August as reported and found on InsiderInsights – see the link the sources section at the end of this article.
The best official news on AXDX is found in its 10-Q for the period ending June 30, 2013. With its rights offering I am sure the Company was likely not wanting to complicate a rights offering with great press releases. We have to read into this one from the 10-Q, and from that filing we see they now have an abundance of cash on hand.
Even their statements see positive where they are talking about the downside: ” …. These forward-looking statements are based on assumptions that the Company will retain key management personnel, the Company will be successful in the development of the BACcel™ system, the Company will obtain sufficient capital to complete the development of the BACcel™ system, the Company will be able to protect its intellectual property, the Company’s ability to respond to technological change, that the Company will accurately anticipate market demand for the Company’s products and that there will be no material adverse change in the Company’s operations or business … ”
Now look at this five year chart:
I am very comfortable with AXDX despite the fact the company is really right near its FIVE YEAR HIGH. Of course nobody should buy at the five year high.